IPO Boutique

Clementia Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Clementia Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Clementia PharmaceuticalsCMTA -
NASDAQ
$13.00-$15.00 $15.00 $18.258 million8/2/2017
Morgan Stanley, Leerink Partners
Co-Manager(s):
Wedbush PacGrow, BTIG
Health Care
Filing(s):

Filed 2017-06-30
Terms Added 2017-07-21



Clementia Pharmaceuticals Quote & Chart - Click for current quote - CMTA

About Clementia Pharmaceuticals (adapted from Clementia Pharmaceuticals prospectus):
They are a clinical stage biopharmaceutical company that is developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CMTA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved